Published in Immunotherapy Weekly, July 18th, 2007
Eighty five people with mild asthma were randomly assigned to receive either five sessions of treatment by the Papworth method on top of their medical care or to continue to rely on usual drug therapy, according to author Correspondence to Elizabeth Holloway, Research Physiotherapist, Department of Epidemiology and Public Health, University College London, Torrington Place, London.
After the sessions...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2007-07-18)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.